Mills Kenneth T. 4
4 · REGENXBIO Inc. · Filed Jun 3, 2025
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
Mills Kenneth T.
Director
Transactions
- Award
Stock Options (Right to Buy)
2025-05-30+39,815→ 39,815 totalExercise: $8.85Exp: 2035-05-30→ Common Stock (39,815 underlying) - Award
Common Stock
2025-05-30+7,768→ 482,871 total
Footnotes (2)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer.
- [F2]The option will vest in 12 equal monthly installments following May 30, 2025 subject to the continuous service of the optionee to the Issuer.